Close Menu

NEW YORK, Nov. 6 – Invitrogen is exploring the possibility of acquiring Incyte Genomics, a source inside Invitrogen told GenomeWeb.    

The source, a senior-level employee who asked not to be named, said that the company is interested in acquiring the genomics data provider but is waiting to act until the price is right.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.